EOLS Shares Outstanding History



Below is a table of the EOLS shares outstanding history going back to 2/8/2018:

Date EOLS Shares Outstanding
2/8/201823.59M
3/23/201823.64M
5/10/201823.64M
8/1/201826.67M
11/1/201827.27M
3/20/201927.27M
4/26/201927.33M
8/6/201927.42M
12/31/201857.30M
11/1/201927.43M
2/21/202033.73M
5/8/202033.73M
8/5/202033.75M
10/26/202033.75M
3/25/202143.73M
5/7/202154.12M
8/2/202154.58M
10/29/202155.58M
2/28/202255.69M
7/29/202256.09M
11/4/202256.25M
5/5/202356.92M
7/28/202356.97M
11/3/202357.15M
3/1/202457.94M

Also see: EOLS Market Cap History
EOLS YTD Return
EOLS Historical Shares Outstanding:
+15.97% CAGR
EOLS Historical Shares Outstanding: +15.97% CAGR

Mouse over chart for data details
2/8/2018 ...3/1/2024
Evolus is a beauty company focused on delivering products in the self-pay aesthetic market. Co.'s commercial product is Jeuveau® (prabotulinumtoxinA-xvfs), a proprietary purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Co.'s primary market is the self-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications that are not reimbursed by any third-party payor, such as Medicaid, Medicare or commercial insurance. We show 25 historical shares outstanding datapoints in our coverage of EOLS's shares outstanding history.

Understanding the changing numbers of EOLS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like EOLS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching EOLS by allowing them to research EOLS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree EOLS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Evolus (EOLS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

EPZM Shares Outstanding History
EQ Shares Outstanding History
ERAS Shares Outstanding History
ERNA Shares Outstanding History
ESPR Shares Outstanding History
ESRX Shares Outstanding History
ETNB Shares Outstanding History
ETON Shares Outstanding History
ETTX Shares Outstanding History
EVFM Shares Outstanding History
More Healthcare companies »

 

EOLS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.